Hyeong Kyu Park
Overview
Explore the profile of Hyeong Kyu Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
606
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoo M, Kim H, Park S, Park S, Park H, Byun D, et al.
J Endocr Soc
. 2025 Jan;
9(1):bvae212.
PMID: 39749109
Context: Subclinical hypothyroidism (SCH) is characterized by elevated thyroid-stimulating hormone (TSH) levels and normal free thyroxine (fT4) levels. In upper normal TSH levels, thyrotropin-releasing hormone (TRH) stimulation test proved to...
2.
Oh E, Cho N, Kang H, Kim S, Park H, Kwon S
PLoS One
. 2023 Dec;
18(12):e0296073.
PMID: 38134035
We investigated the differences in quantity and quality of skeletal muscle between metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO) individuals using abdominal CT. One hundred and seventy-two people...
3.
Park H, Kim K, Min K, Sohn T, Jeong I, Ahn C, et al.
Diabetes Obes Metab
. 2023 Jun;
25(9):2743-2755.
PMID: 37337747
Aims: To evaluate the effect of dapagliflozin on body composition such as total body fat (BF) mass, abdominal visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) areas compared with...
4.
Kim H, Park S, Park H, Byun D, Suh K, Yoo M
BMC Nephrol
. 2023 Mar;
24(1):64.
PMID: 36949396
Background: Chronic kidney disease (CKD) has a significant impact on global health. Studies have shown that subclinical thyroid dysfunction may be related to CKD, but the association between subclinical thyroid...
5.
Kim H, Kwon S, Park S, Byun D, Suh K, Yoo M, et al.
PLoS One
. 2022 Dec;
17(12):e0279494.
PMID: 36584082
Background: Recent studies have indicated that the triglyceride-glucose (TyG) index or subclinical thyroid dysfunction is associated with carotid plaques, a predictor of cardiovascular disease risk. However, evidence for this association...
6.
Kim H, Park S, Park S, Park H, Byun D, Suh K, et al.
Endocr J
. 2022 Dec;
70(4):393-401.
PMID: 36567075
Metabolic syndrome (MetS) is considered very important because of the increased risk for cardiovascular diseases. Identifying modifiable factors may help prevent MetS. We aimed to investigate the relationship between iodine...
7.
Lee Y, Kim D, Yu J, Choi K, Kim S, Park K, et al.
Diabetes Obes Metab
. 2022 Dec;
25(5):1174-1185.
PMID: 36564983
Aim: To determine whether the twice-daily (BID) regimen is superior to the once-daily (QD) regimen for managing glycaemic variability by comparing the effects of anagliptin 100 mg BID versus sitagliptin...
8.
Lee H, Kim H, Jeon J, Noh H, Park R, Byun D, et al.
Sci Rep
. 2022 Nov;
12(1):19103.
PMID: 36351983
Sodium-glucose co-transporter 2 (SGLT2) inhibitors improve cardiovascular and renal outcomes in type 2 diabetes mellitus (T2DM) patients. However, the mechanisms by which SGLT2 inhibitors improve the clinical outcomes remain elusive....
9.
Kim H, Park S, Park H, Byun D, Suh K, Yoo M
PLoS One
. 2022 Jul;
17(7):e0270126.
PMID: 35867637
Background: The association between thyroid hormone levels and pulmonary function in euthyroid population is still unclear. We aimed to examine the relationship between thyroid function and lung function in a...
10.
Kim H, Park S, Park H, Byun D, Suh K, Yoo M
J Gastroenterol Hepatol
. 2022 Apr;
37(8):1617-1623.
PMID: 35434848
Background And Aim: The association between thyroid autoimmunity and nonalcoholic fatty liver disease (NAFLD) remains unclear. In this study, we aimed to investigate the relationship between thyroid autoimmunity and NAFLD...